1. Home
  2. CVRX
Logo CVRx Inc.

CVRX

CVRx Inc.

as 05-30-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Founded: 2000 Country:
United States
United States
Employees: N/A City: MINNEAPOLIS
Market Cap: 202.8M IPO Year: 2021
Target Price: $14.50 AVG Volume (30 days): 516.1K
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.17 EPS Growth: N/A
52 Week Low/High: $4.30 - $18.55 Next Earning Date: 05-08-2025
Revenue: $52,870,000 Revenue Growth: 25.62%
Revenue Growth (this year): 13.92% Revenue Growth (next year): 19.89%

CVRX Daily Stock ML Predictions

Stock Insider Trading Activity of CVRx Inc. (CVRX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Nielsen Kirk G. CVRX Director May 15 '25 Buy $5.45 10,966 $59,795.40 1,910,134
Hykes Kevin CVRX PRES & CEO May 12 '25 Buy $4.84 5,000 $24,200.00 133,000
Jain Mudit K. CVRX Director May 12 '25 Buy $4.96 1,650 $7,774.95 4,900

Share on Social Networks: